The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pharmacokinetic (PK) assessment of dacomitinib (D) in patients with locoregionally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through gastrostomy feeding tube (GT).
Joanne Wing-Yan Chiu
No relevant relationships to disclose
Kelvin K. Chan
No relevant relationships to disclose
Lillian L. Siu
Research Funding - Pfizer
Eric Xueyu Chen
No relevant relationships to disclose
Albiruni R. A. Razak
Research Funding - Pfizer